CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 25,000 shares at $161.11 ($4,027,750)
- 4 Planned sale Chief Operating Officer sold 35,378 shares at $161.88 ($5,726,991)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 6,250 shares (option exercise)
- 4 Option exercise Director acquired 12,485 shares (option exercise)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Option exercise Director acquired 5,193 shares (option exercise)
- 4 Planned sale Chief Executive Officer sold 32,410 shares at $185.60 ($6,015,296)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 12,000 shares at $187.92 ($2,255,040)
- 4 Planned sale Chief Commercial Officer sold 7,500 shares at $184.44 ($1,383,300)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Results of operations · Other events
- 4 Planned sale Chief Executive Officer sold 139,414 shares at an average $171.30 ($23,881,618)
Page 4 of 34 · 672 filings